Your browser doesn't support javascript.
loading
CRISPR/Cas9-mediated gene deletion efficiently retards the progression of Philadelphia-positive acute lymphoblastic leukemia in a p210 BCR-ABL1T315I mutation mouse model.
Tan, Yu-Ting; Ye, Lin; Xie, Fei; Wang, Jiaming; Müschen, Markus; Chen, Sai-Juan; Kan, Yuet Wai; Liu, Han.
Afiliação
  • Tan YT; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China yuting.tan@aliyun.com liuhan68@sjtu.edu.cn yw.kan@ucsf.edu sjchen@stn.sh.cn.
  • Ye L; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Xie F; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Wang J; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Müschen M; Present address: Eureka Therapeutics, Emeryville, CA, USA.
  • Chen SJ; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Kan YW; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Liu H; Department of Systems Biology, City of Hope Comprehensive Cancer Center, Monrovia, CA, USA.
Haematologica ; 105(5): e232-e236, 2020 05.
Article em En | MEDLINE | ID: mdl-31537693

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Sistemas CRISPR-Cas Limite: Animals Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Sistemas CRISPR-Cas Limite: Animals Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article